Bionovo, Inc. (NASDAQ: BNVI) 26.3% HIGHER; announced today the publication of results from its study on the anti-tumor mechanism of BN107. The results of the study, published in the International Journal of Cancer, describe the potential molecular mechanisms mediating the selective pro-apoptotic (cell death) effect induced by BN107 on estrogen receptor negative breast cancer cells. Click here to see the results.

AspenBio Pharma, Inc. (NASDAQ: APPY) 23.8% HIGHER; reported on its progress and plans for the Premarket Notification 510(k) submission of its ELISA format AppyScore test. AppyScore is the first blood-based test designed to aid in the evaluation